X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Fact Sheet, Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Fact Sheet   (ALKE)

Here is the latest financial fact sheet of . For more details, see the quarterly results and share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALKEM LABORATORIES Price History

Price Rs 1,861.0
Mkt Cap Rs m 222,510
Vol '000 1.1
P/E X  
P/CF X 28.3
EPS (TTM) Rs 0.0
% ch % 1.3
No. of shares m 119.57
% ch week % 1.6
% ch 1-mth % 4.6
% ch 12-mth % 10.5
52 week H/L Rs 2,238.0/1,400.0
(As on Oct 23, 2017 03:08:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALKEM LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
ALKEM LABORATORIES EQUITY SHARE DATA
High RsNA1,589 
Low RsNA1,232 
Sales per share (Unadj.) Rs313.1417.5 
Earnings per share (Unadj.) Rs32.756.3 
Diluted earnings per shareRs32.856.3 
Cash flow per share (Unadj.) Rs38.764.7 
Dividends per share (Unadj.) Rs012.70 
Adj. dividends per shareRs0.0012.70 
Dividend yield (eoy) %NM0.9 
Book value per share (Unadj.) Rs250.8292.9 
Adj. book value per shareRs250.8292.9 
Shares outstanding (eoy) m119.57119.57 
Bonus/Rights/Conversions  -- 
Price / Sales ratio x03.4 
Avg P/E ratio x025.1 
P/CF ratio (eoy) x021.8 
Price / Book Value ratio x04.8 
Dividend payout %022.6 
Avg Mkt Cap Rs m0168,653 
No. of employees `000NANA 
Total wages/salary Rs m6,4599,171 
Avg. sales/employee Rs ThNMNM 
Avg. wages/employee Rs ThNMNM 
Avg. net profit/employee Rs ThNMNM 
ALKEM LABORATORIES INCOME DATA
Net Sales Rs m37,43449,915 
Other income Rs m1,8101,645 
Total revenues Rs m39,24451,561 
Gross profit Rs m4,2188,482 
Depreciation Rs m7091,006 
Interest Rs m811671 
Profit before tax Rs m4,5088,451 
Minority Interest Rs m0-114 
Prior Period Items Rs m00 
Extraordinary Inc (Exp) Rs m00 
Tax Rs m5921,606 
Profit after tax Rs m3,9166,731 
Gross profit margin %11.317.0 
Effective tax rate %13.119.0 
Net profit margin %10.513.5 
ALKEM LABORATORIES BALANCE SHEET DATA
Current assets Rs m23,38127,062 
Current liabilities Rs m20,06015,324 
Net working cap to sales %8.923.5 
Current ratio x1.21.8 
Inventory Days Days7667 
Debtors Days Days5141 
Net fixed assets Rs m11,42912,610 
Share capital Rs m239239 
"Free" reserves Rs m29,58834,490 
Net worth Rs m29,99135,027 
Long term debt Rs m3341,212 
Total assets Rs m52,95854,387 
Interest coverage x6.613.6 
Debt to equity ratio x00 
Sales to assets ratio x0.70.9 
Return on assets %8.913.6 
Return on equity %13.119.2 
Return on capital %17.524.9 
Exports to sales %9.212.9 
Imports to sales %3.93.1 
Exports (fob) Rs m3,4446,461 
Imports (cif) Rs m1,4561,540 
Fx inflow Rs m3,5166,563 
Fx outflow Rs m2,5903,012 
Net fx Rs m9263,552 
ALKEM LABORATORIES CASH FLOW
From Operations Rs m 3,255 7,259 
From Investments Rs m -2,370 1,864 
From Financial Activity Rs m -518 -9,273 
Net Cashflow Rs m 367 -150 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 66.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 33.1%
FIIs 0.0%
ADR/GDR 0.0%
Free float 0.0%
Shareholders 68,381
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai-13
E-MAIL investors@alkem.com WEB www.alkemlabs.com
TELEPHONE 02239829999 FAX
SECTOR PHARMACEUTICALS GROUP
TR AGENT Link Intime India Pvt Ltd
CHM: Mr. Samprada Singh COMP SEC: Mr. Manish Narang YEAR OF INC: 1973 BSE CODE: 539523 FV (Rs): 2 DIV YIELD (%): 0.7

More Pharmaceuticals Company Fact Sheets:   INDRAPRASTHA MEDICAL  FULFORD INDIA  BIOCON LTD  NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare ALKEM LABORATORIES With:   INDRAPRASTHA MEDICAL  FULFORD INDIA  BIOCON LTD  NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Pares Gains; Telecom Stocks Rally(01:30 pm)

After opening the day on a firm note, the Indian share markets pared its morning gains to trade flat. Sectoral indices are trading mixed, with stocks in the realty sector.

Views on news

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

Timeless Stocks on the Electric Car Assembly Line(The 5 Minute Wrapup)

Oct 10, 2017

Are they on their way to create Coca Cola-like wealth?

Why Merger of Public Sector Banks Continues to Be a Bad Idea(Vivek Kaul's Diary)

Oct 10, 2017

There is enough research evidence that suggests that most mergers don't work.

Electric Vehicles: The Final Piece of the Puzzle(Smart Contrarian)

Oct 16, 2017

Just as there would be gainers from an electric vehicles boom, who possibly could be the biggest losers.

Mutual Funds Re-categorised... But What About Stocks?(Daily Profit Hunter)

Oct 11, 2017

The market regulator can solve systemic issues but you must tackle the behavioral biases on your own.

Companies Are Wary of Borrowing(Chart Of The Day)

Oct 17, 2017

How to profit from behavioral biases afflicting the industry.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - ALEMBIC PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS